Friday, September 16, 2011

Postponement of full Mandatory recording date

According to the HSA website , the full implementation of mandatory recording for P medicines/POM with exemptions for limited sale and supply without prescription will be effective from 1 Feb 2012.

However, more P medicines will be subjected to mandatory recording starting 1st Oct. As follows:


Recently reclassified P medicines are Desloratidine, Bromhexine 8mg tablets, Fexofenadine 120mg (but Telfast is 180mg so we have yet any preparations with this ingredient and strength to sell without prescription), Triamcinolone acetonide paste (note it is PASTE only so Oral-aid lotion is still under prescription sadly).

Some of these reclassified medicines are also bound by a restriction on supply quantity and age of use.

All the newly reclassified P medicines are subjected to mandatory recording. Do seek advice and proper usage of these medicines from your pharmacist, and provide details of your medical conditions and/or drug allergy for assessment.

Public are advised to report adverse effects, should they experience any, during the use of P medicines to their pharmacist so that the adverse effects can be promptly reported to the Vigilance Branch of HSA.

blogger widgets

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...